The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma.
CONCLUSION: Our data suggest a new therapeutic role for mifamurtide as possible anti-resorption agent in chemotherapy-induced osteoporosis in children with osteosarcoma.
PMID: 27993113 [PubMed - as supplied by publisher]
Source: Current Cancer Drug Targets - Category: Cancer & Oncology Authors: Giulia B, Daniela DP, Chiara T, Iolanda M, Francesca P, Fiorina C, Francesca R Tags: Curr Cancer Drug Targets Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Chemotherapy | Childhood Cancer | Children | Hyperactivity | Orthopaedics | Osteoporosis | Osteosarcoma